Skip to main content
Livermore
Livermore
ZHEN

Royalty Pharma plc

RPRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001802768

In the last 90 days, Royalty Pharma plc insiders filed 0 open-market purchases and 5 sales; 650 institutions reported holding it in 13F filings for Q2 2026, worth $20.6B in total; Dorsey Asset Management is the only superinvestor holding it.

Superinvestors holding RPRX, Q2 2026

1 superinvestor reports holding Royalty Pharma plc on Form 13F, worth $137.7M in total. Weight is Royalty Pharma plc's share of each 13F portfolio; actions compare shares with Q1 2026.

See all superinvestors
Superinvestors holding RPRX in Q2 2026
Superinvestor% of portfolioSharesValuevs. previous quarter
Dorsey Asset ManagementPat Dorsey8.8%2,456,528$137.7MAdded+7.9%

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of RPRX each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q2 2026

    1 superinvestor holding at quarter end

    Added
    Dorsey Asset Management (+7.9%)

  2. Q1 2026

    1 superinvestor holding at quarter end

    Added
    Dorsey Asset Management (+0.8%)

  3. Q4 2025

    1 superinvestor holding at quarter end

    Reduced
    Dorsey Asset Management (−3.9%)

  4. Q3 2025

    1 superinvestor holding at quarter end

    New
    Dorsey Asset Management
    Sold out
    Viking Global Investors

  5. Q2 2025

    1 superinvestor holding at quarter end

    Reduced
    Viking Global Investors (−75.4%)

  6. Q1 2025

    1 superinvestor holding at quarter end

    Reduced
    Viking Global Investors (−13.5%)

  7. Q4 2024

    1 superinvestor holding at quarter end

    Added
    Viking Global Investors (+0.9%)

  8. Q3 2024

    1 superinvestor holding at quarter end

    Added
    Viking Global Investors (+1.0%)

  9. Q2 2024

    1 superinvestor holding at quarter end

    Added
    Viking Global Investors (+4.2%)

  10. Q1 2024

    1 superinvestor holding at quarter end

    Added
    Viking Global Investors (+13.9%)

  11. Q4 2023

    1 superinvestor holding at quarter end

    Added
    Viking Global Investors (+6.6%)

  12. Q3 2023

    1 superinvestor holding at quarter end

    Reduced
    Viking Global Investors (−3.9%)

  13. Q2 2023

    1 superinvestor holding at quarter end

    Reduced
    Viking Global Investors (−12.1%)

  14. Q1 2023

    1 superinvestor holding at quarter end

    Added
    Viking Global Investors (+11.9%)

  15. Q4 2022

    1 superinvestor holding at quarter end

    Reduced
    Viking Global Investors (−8.0%)

  16. Q3 2022

    1 superinvestor holding at quarter end

    Reduced
    Viking Global Investors (−12.0%)

  17. Q2 2022

    1 superinvestor holding at quarter end

    Added
    Viking Global Investors (+14.9%)
    Sold out
    Berkshire Hathaway

  18. Q1 2022

    2 superinvestors holding at quarter end

    Added
    Viking Global Investors (+4.4%)
    Reduced
    Berkshire Hathaway (−82.7%)

  19. Q4 2021

    2 superinvestors holding at quarter end

    Added
    Viking Global Investors (+149.1%)
    Reduced
    Berkshire Hathaway (−34.2%)

  20. Q3 2021

    2 superinvestors holding at quarter end

    New
    Berkshire Hathaway
    Added
    Viking Global Investors (+27.8%)

  21. Q2 2021

    1 superinvestor holding at quarter end

    Added
    Viking Global Investors (+57.1%)
    Sold out
    Maverick Capital